HealthEquity (FRA:2HE) EBIT: €303 Mil (TTM As of Apr. 2026)


FRA:2HE HealthEquity Inc FRA:2HE
92 GF Score
Price €72.00
GF Value €83.82
! 1 Warning Sign
View Full Analysis

What is HealthEquity EBIT?

HealthEquity FRA:2HE -4.00% 92 EBIT is €303 Mil as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 92/100 and a GF Value™ of €83.82. The stock has 1 warning sign investors should review.

HealthEquity's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2026 was €90 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2026 was €303 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. HealthEquity's annualized ROC % for the quarter that ended in Apr. 2026 was 10.60%. HealthEquity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 421.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. HealthEquity's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 4.24%.


HealthEquity  (FRA:2HE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

HealthEquity's annualized ROC % for the quarter that ended in Apr. 2026 is calculated as:

ROC % (Q: Apr. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2026 ) + Invested Capital (Q: Apr. 2026 ))/ count )
=355.904 * ( 1 - 24.88% )/( (2531.605 + 2515.117)/ 2 )
=267.3550848/2523.361
=10.60 %

where

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2876.663 - 73.651 - ( 271.407 - max(0, 133.479 - 435.951+271.407))
=2531.605

Invested Capital(Q: Apr. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2826.789 - 84.782 - ( 226.89 - max(0, 116.058 - 398.881+226.89))
=2515.117

Note: The Operating Income data used here is four times the quarterly (Apr. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

HealthEquity's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2026  Q: Apr. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=359.104/( ( (33.603 + max(39.499, 0)) + (32.813 + max(64.411, 0)) )/ 2 )
=359.104/( ( 73.102 + 97.224 )/ 2 )
=359.104/85.163
=421.67 %

where Working Capital is:

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(105.265 + 0 + 59.279) - (73.651 + 0 + 51.394)
=39.499

Working Capital(Q: Apr. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(104.313 + 0 + 67.678) - (84.782 + 0 + 22.798)
=64.411

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

HealthEquity's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2026 )
=302.675/7142.522
=4.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity EBIT Related Terms


HealthEquity EBIT Historical Data

* Premium members only.

The historical data trend for HealthEquity's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity EBIT Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.67 9.58 119.79 170.66 284.71

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.37 79.70 70.08 63.12 89.78

FRA:2HE vs HNGE, TEM, TXG: EBIT Comparison

For the Health Information Services subindustry, HealthEquity's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where HealthEquity's EV-to-EBIT falls into.


FRA:2HE
92GF Score
HealthEquity Inc FRA:2HE
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €303 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €303 Mil mean?
HealthEquity (FRA:2HE) has a EBIT of €303 Mil as of Apr. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on HealthEquity.
Is HealthEquity's EBIT too high?
HealthEquity's current EBIT is €303 Mil. Overall, HealthEquity has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's EBIT compare to HNGE and TEM?
HealthEquity's EBIT of €303 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on HealthEquity. HealthEquity's current EBIT is €303 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current EBIT of €303 Mil. The stock's GF Value™ is €83.82, compared to a current price of €72.00 — trading 14.1% below its estimated fair value. The current EBIT is €303 Mil. HealthEquity's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current EBIT is €303 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €72.00 is trading 14.1% below its estimated GF Value™ of €83.82.

Key valuation signals for FRA:2HE:

  • EBIT: €303 Mil
  • GF Value™: €83.82 vs. price of €72.00 (14.1% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
92GF Score

Get the complete analysis for FRA:2HE

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€72.00
Price
€83.82
GF Value